臨床分子病態検査学講座

Keyphrases

1. Temperature Mapping 100%
2. Mapping Method 100%
3. Melting Temperature 93%
4. Preterm Labor 82%
5. Clinical Laboratory 58%
6. Rapid Identification 57%
7. Intrauterine Inflammation 56%
8. Thermostable DNA Polymerase 51%
9. Eukaryotes 51%
10. Recombinase Polymerase Amplification 49%
11. Bacteremia 47%
12. Amniotic Fluid 46%
13. COVID-19 46%
14. Antithrombin Deficiency 42%
15. Pathogenic Microorganisms 42%
16. University Hospital 40%
17. Mycoplasma 37%
18. Ureaplasma 37%
19. Male DNA 37%
20. Cerebrospinal Fluid 37%
21. Neutralizing Antibodies 37%
22. Adenosine Triphosphate 37%
23. Mesenchymal Cells 37%
24. Transforming Growth Factor-β 37%
25. Neutralizing Activity 33%
26. Microorganisms 33%
27. Sepsis 32%
28. Rapid Detection 31%
29. Blood Culture 30%
30. Omicron Variant 29%
31. Highly Sensitive 27%
32. Blood Samples 27%
33. Intact Membrane 27%
34. Bacterial DNA 26%
35. SARS-CoV-2 Infection 25%
36. DNA Contamination 25%
37. Fluorescence Correlation Spectroscopy 24%
38. Intra-amniotic 24%
39. Laboratory Examination 23%
40. Japan 23%
41. Magnetic Resonance Imaging 22%
42. Antithrombin 22%
43. Amniotic Fluid Infection 21%
44. Polymerase Chain Reaction 21%
45. Week of Gestation 21%
46. Bacterial Infection 21%
47. Perinatal Prognosis 21%
48. Microbes 21%
49. Loop-mediated Isothermal Amplification Assay 21%
50. Antibiotic Therapy 21%
51. High-throughput 21%
52. Quenching Probe 20%
53. Growth Arrest 20%
54. Bleeding Disorders 20%
55. Omicron BA.5 19%
56. Potential Biomarkers 19%
57. Antibody Level 19%
58. Cortical Vein Thrombosis 18%
59. Accreditation 18%
60. Slackia Exigua 18%
61. Hypervirulent Klebsiella Pneumoniae 18%
62. S. Exigua 18%
63. 17-hydroxyprogesterone (17-OHP) 18%
64. Genetic Diagnostics 18%
65. Splicing Abnormality 18%
66. Stroke-like Episode 18%
67. Adenosine Triphosphate Bioluminescence 18%
68. Hereditary Hemochromatosis 18%
69. Casirivimab-imdevimab 18%
70. Imdevimab 18%
71. Casirivimab 18%
72. Popliteal Vein 18%
73. Catheter-directed Thrombolysis 18%
74. Parvimonas Micra 18%
75. Spondylodiscitis 18%
76. Polymicrobial 18%
77. Amniotic Fluid Sludge 18%
78. ISO 15189 18%
79. Levofloxacin Resistance 18%
80. Sludge 18%
81. Notch Signaling 18%
82. Antigen Levels 18%
83. Multiple Sclerosis 18%
84. Blood Culture Bottles 18%
85. Type I Interferon 18%
86. Second Booster 18%
87. Bivalent Vaccine 18%
88. Mitochondrial Myopathy 18%
89. Leg Edema 18%
90. Bleeding Risk 18%
91. Candida Species 18%
92. Quantification Assay 18%
93. Klebsiella Pneumoniae (K. pneumoniae) 18%
94. Testing System 18%
95. XN-series 18%
96. Sysmex XN 18%
97. Hematology Analyzer 18%
98. Cell Population Data 18%
99. Huh7 18%
100. In Vivo Evidence 18%

Medicine and Dentistry

1. Infection 55%
2. Antithrombin III Deficiency 46%
3. Premature Labor 42%
4. Magnetic Resonance Imaging 37%
5. Bacterial Infection 30%
6. Bloodstream Infection 29%
7. Sepsis 28%
8. DNA Polymerase 27%
9. Blood Culture 24%
10. Amnion Fluid 23%
11. Pregnancy 23%
12. Laboratory Test 23%
13. Antibiotic Therapy 22%
14. Polymerase Chain Reaction 21%
15. Bleeding Disorder 20%
16. Antithrombin 20%
17. Magnetic Resonance Venography 18%
18. Cerebral Venous Sinus Thrombosis 18%
19. Multiple Sclerosis 18%
20. Hemochromatosis 18%
21. Klebsiella pneumoniae 18%
22. Gestation Period 18%
23. Blood Clotting Factor 7 Deficiency 18%
24. Parvimonas micra 18%
25. Pyogenic Liver Abscess 18%
26. Blood Clot Lysis 18%
27. Phlebothrombosis 18%
28. Nonsense Mutation 18%
29. Renal Cyst 18%
30. Bone Biopsy 18%
31. Loop-Mediated Isothermal Amplification 18%
32. Factor X 18%
33. Deep Vein Thrombosis 18%
34. Open Heart Surgery 18%
35. Eye Infection 18%
36. Intervertebral Disk Degeneration 18%
37. Cell Line 18%
38. Bacterial DNA 18%
39. Pre-Eclampsia 18%
40. Growth Disorder 18%
41. COVID-19 18%
42. Pneumococcus 18%
43. Interleukin 6 18%
44. Single Isomorphous Replacement 18%
45. Paresthesia 15%
46. Anticoagulant Therapy 15%
47. Bleeding 15%
48. Messenger RNA 15%
49. Hemostat 14%
50. Retrospective Study 14%
51. Bayley Scales of Infant Development 14%
52. Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry 13%
53. Popliteal Vein 12%
54. Infusion 12%
55. Leg Edema 12%
56. Substitution Therapy 12%
57. Thrombus 12%
58. Methicillin Resistant Staphylococcus Aureus 12%
59. Case Presentation 12%
60. Omicron Coronavirus Variant 11%
61. Pathogen 10%
62. Thrombosis 10%
63. Diagnosis 10%
64. Antiinfective Agent 10%
65. Real-Time Polymerase Chain Reaction 10%
66. Sagittal Sinus Thrombosis 9%
67. T Follicular Helper Cell 9%
68. Panton Valentine Leukocidin 9%
69. Blood Clotting Factor 10 Deficiency 9%
70. Hypoxemia 9%
71. Fluorescence Analysis 9%
72. Halomonas 9%
73. Hematology 9%
74. Cell Population 9%
75. Recombinase 9%
76. Parietal Lobe 9%
77. Gram Positive Cocci 9%
78. Arm 9%
79. Developmental Disorder 9%
80. Spastic Diplegia 9%
81. Gram Staining 9%
82. Hemiparesis 9%
83. Apoplexy 9%
84. Low Back Pain 9%
85. Maturity Onset Diabetes of the Young 9%
86. Severe Acute Respiratory Syndrome Coronavirus 2 9%
87. Reverse Transcription 9%
88. Methicillin Resistant Staphylococcus Aureus Infection 9%
89. Antibody Response 9%
90. Decision Making 9%
91. Lymphadenitis 9%
92. Prospective Study 9%
93. Neutralizing Antibody 9%
94. Polymerase 9%
95. Immunity 9%
96. Respiratory Failure 9%
97. Disease 9%
98. Pediatrics Patient 9%
99. Biopsy Technique 9%
100. Pediatrics 9%